2018
DOI: 10.1021/acs.cgd.8b00216
|View full text |Cite
|
Sign up to set email alerts
|

Cocrystal Forms of the BCS Class IV Drug Sulfamethoxazole

Abstract: Sulfamethoxazole, smz, is an antibiotic which is classified as a Biopharmaceutics Classification System (BCS) class IV, low solubility and low permeability drug. Co-crystal formation has been examined in an attempt to improve solubility. Both ball milling and crystallization from solution have been examined. Ball milling showed that thirteen co-formers gave new crystalline X-ray powder patterns and four gave X-ray amorphous patterns while crystallization from solution gave single crystals of four co-crystals a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
25
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 30 publications
(25 citation statements)
references
References 41 publications
0
25
0
Order By: Relevance
“…Karki, et al [240] demonstrated that synthon analysis combined with Fabian's methodology was effective in prediction of possible co-formers for artemisinin. A series of co-crystals of sulfamethoxazole [241] and leflunomide [242] were synthesized using this approach. Prediction of possible H-bonded motifs between tyraminium cations and violurate anions also successfully predicted many of the bimolecular synthons experimentally observed in tyraminium violurate polymorphs and hydrates, but also demonstrated that none of the trimolecular synthons were predicted [243].…”
Section: Co-crystals Designmentioning
confidence: 99%
“…Karki, et al [240] demonstrated that synthon analysis combined with Fabian's methodology was effective in prediction of possible co-formers for artemisinin. A series of co-crystals of sulfamethoxazole [241] and leflunomide [242] were synthesized using this approach. Prediction of possible H-bonded motifs between tyraminium cations and violurate anions also successfully predicted many of the bimolecular synthons experimentally observed in tyraminium violurate polymorphs and hydrates, but also demonstrated that none of the trimolecular synthons were predicted [243].…”
Section: Co-crystals Designmentioning
confidence: 99%
“…Cocrystals, defined as “crystalline phase materials composed of two or more molecular and/or ionic compounds generally in a stoichiometric ratio”, show great potential in the pharmaceutical field . The formation of pharmaceutical cocrystals changes the fundamental molecular conformation and crystal-packing patterns, thereby modulating the physicochemical properties of the active pharmaceutical ingredient (API), such as solubility, dissolution rate, stability, and bioavailability. Cooling and evaporation from solution are widely used crystallization methods in the laboratory to obtain cocrystals. However, experimental screening of cocrystals is usually time-consuming, labor-intensive, and expensive.…”
Section: Introductionmentioning
confidence: 99%
“…It belongs to class IV of the Biopharmaceutics Classification System: i.e., it has low solubility and permeability . There are several known crystal forms of SMX, including five polymorphs, a hemihydrate, , and a series of salts and cocrystals. ,, Crystal structures of polymorphs I and II were determined in the early 1980s, , both of the monoclinic crystal system, with C 2/ c symmetry. In 2005, two new SMX polymorphs were discovered using different polymers as nucleation centers .…”
Section: Introductionmentioning
confidence: 99%